Catherine Ferguson, vice president of federal advocacy for the American Diabetes Assn
Its crucial for patients to understand that while GLP-1 medications are revolutionary tools that accelerate weight lossto reach their goals they still need to make [healthy] lifestyle changes, fix relationships with food, and work on exercise consistency
In one real-world case, a primary care practice submitted a prior authorization request for a patient with a BMI over 30 but lacking any history of formal lifestyle intervention
Mounting evidence shows that type 2 diabetes (T2DM) significantly increases CRC risk, likely due to shared risk factors (e.g., obesity, age, poor diet) and metabolic dysregulation, such as elevated glucose and insulin levels
M., Kynaston, L., Naseem, S., Proudman, E., & Laceby, D